Vernalis

Vernalis collaborates with a wide range of organisations to enable drug discovery programs through both short- and long-term projects. By applying our deep and wide expertise in structure-based drug discovery, built over twenty-five years of partnerships and innovation to enable challenging targets, we can express and engineer your proteins, find and validate hits and help to evolve your chemical series into pre-clinical candidates. And we can do all this in-house at our fully equipped laboratories in Cambridge UK.

Ben Davis
LinkedIn logo Research Fellow and Director of Business Development 

ViaNautis

ViaNautis is exploiting its proprietary technology, polyNaut®, a nanovesicle platform using advanced polymer materials and machine learning, to direct nucleic acid therapeutics to the specific site of action with unparalleled precision.
Sam Barker
LinkedIn logo Chief Business Officer